Shoulder Innovations, Inc. ((SI)) announced an update on their ongoing clinical study.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shoulder Innovations, Inc. is conducting a study titled ‘Shoulder Innovations Clinical Data Registry’ to gather long-term clinical outcomes for anatomic and reverse total shoulder arthroplasty. This observational study aims to provide valuable insights into shoulder replacement procedures, which are crucial for improving patient care and advancing medical knowledge in this field.
The study focuses on shoulder arthroplasty, a type of shoulder replacement surgery. It is designed to observe and collect data on the effectiveness and outcomes of these procedures over a significant period.
The study is observational, following a cohort model with a prospective time perspective. It will span ten years, allowing for comprehensive data collection and analysis. The study does not involve any specific allocation or masking, as it is purely observational.
The study began on December 13, 2024, with the latest update submitted on July 17, 2025. These dates are crucial as they mark the progression and ongoing nature of the study, ensuring that the data collected remains relevant and up-to-date.
For investors, this study could signal a positive development for Shoulder Innovations, potentially enhancing its market position and stock performance. As the study progresses, it may influence investor sentiment and provide a competitive edge in the shoulder replacement industry.
The study is currently recruiting, and further details are available on the ClinicalTrials portal.